Jun 4, 2021: We now bring you the HES profile from UK
Containing over 80M patients, the Hospital Episode Statistics (HES) Database (United Kingdom) consists of all secondary care activity in England starting April 2009. Data are collected by all NHS Trusts in England and reported on a monthly basis. Patient characteristics are also included in the database, such as age, gender and ethnicity.
Hospital Episode Statistics (HES) Database (United Kingdom)
Database Contact Data
Hannah Matthews
Email: hannahmatthews@openhealthgroup.com
Alternate Contact
1. Email: support@harveywalsh.co.uk
2. You may also try completing the contact form at: https://www.openhealthgroup.com/contact-us
References of Studies Using/Describing Database
1. Beecroft S, O’Connell M, Nassar A, Noon K, Pollock KG, Palmer D, Cross TJ. Major variation in hepatocellular carcinoma treatment and outcomes in England: a retrospective cohort study. Frontline Gastroenterology. 2023 Jan 1;14(1):19-24.
2. Cox T, O’Connell M, Leeuwenkamp O, Palimaka S, Reed N. Real-world comparison of healthcare resource utilization and costs of [177Lu] Lu-DOTA-TATE in patients with progressive neuroendocrine tumors in England: a matched cohort analysis using data from the hospital episode statistics dataset. Current Medical Research and Opinion. 2022 Aug 3;38(8):1305-17.
3. Yakutcan U, Demir E, Hurst JR, Taylor PC, Ridsdale HA. Operational modeling with health economics to support decision making for copd patients. Health Services Research. 2021 Dec;56(6):1271-80.
4. Shah A, Hawley S, Inman DS, Cooper C, Fagan E, Johansen A, Judge A. Geographical variation in surgical care and mortality following hip fracture in England: a cohort study using the National Hip Fracture Database (NHFD). Osteoporosis International. 2021 Oct 1:1-0.
5. Parry-Smith W, Okoth K, Subramanian A, Gokhale KM, Chandan JS, Humpston C, Coomarasamy A, Nirantharakumar K, Šumilo D. Postpartum haemorrhage and risk of mental ill health: A population-based longitudinal study using linked primary and secondary care databases. J Psychiatr Res. 2021 May;137:419-425.
6. Keltie K, Cognigni P, Gross S, Urwin S, Burn J, Cole H, Berry L, Patrick H, Sims A. Comparison of identifiable and non-identifiable data linkage: health technology assessment of MitraClip using registry, administrative and mortality datasets. BMJ Health Care Inform. 2021 Apr;28(1):e100223.
7. Baskaran V, Pearce F, Harwood RH, McKeever TM, Lim WS. Primary care consultations after hospitalisation for pneumonia: a large population-based cohort study. Br J Gen Pract. 2021 Mar 26;71(705):e250-e257.
8. Bhamra N, Osborne MS, Balai E, Jolly K, Barraclough J. Prevalence of Patients Who Return to Theatre Post-Adenoidectomy: A Review of Hospital Episode Statistics Data (2012-2019). Cureus. 2021 Mar 18;13(3):e13980.
9. Stephens S, Chatterjee A, Coles V, Crawford R. The costs of treating vaginal and vulval cancer in England (2009–2015). BMC Public Health. 2020 Dec;20(1):1-8.
10. De Oliveira H, Prodel M, Lamarsalle L, Inada-Kim M, Ajayi K, Wilkins J, Sekelj S, Beecroft S, Snow S, Slater R, Orlowski A. “Bow-tie” optimal pathway discovery analysis of sepsis hospital admissions using the Hospital Episode Statistics database in England. JAMIA open. 2020 Oct;3(3):439-48.
May 19, 2021: B.R.I.D.G.E. is for Professors & Grad Students too!
Read our latest newsletter to learn more about B.R.I.D.G.E. and how it can help academia – Professors and Grad students.
Apr 29, 2021: The German Centre for Cancer Registry Data (ZfKD) marks the 340th database profile
With data starting from 1999 and around 500,000 cancer patients being added each year, the population-based cancer registries in each German federal state transfer data to the German Centre for Cancer Registry Data (ZfKD). ZfKD estimates national cancer incidence, prevalence and survival rates after assessing the completeness of the data recorded in the individual registries. The basic method is that the data are first checked for completeness of incidence and of vital status.
German Centre for Cancer Registry Data (ZfKD) (Germany)
Database Contact Data
1. Klaus Kraywinkel, MD, MSc (Epidemiology)
Centre for Cancer Registry Data at the Robert Koch-Institute
General-Pape-Str. 62-66
D-12101 Berlin
GERMANY
Phone: +49-30187543170
Email: k.kraywinkel@rki.de
2. Please complete the contact form at:
https://www.krebsdaten.de/Krebs/DE/Content/ZfKD/Kontakt/kontakt_node.html;jsessionid=675E5BAEEA85BCACA037D83E2CF2178B.internet122
Alternate Contact
Nina Buttmann-Schweiger, MD, MSc (Epidemiology)
Centre for Cancer Registry Data at the Robert Koch-Institute
General-Pape-Str. 62-66
D-12101 Berlin
GERMANY
Phone: +49-3018754-3266
Email: ButtmannN@rki.de
References of Studies Using/Describing Database
1. Gerber TS, Strobl S, Marx A, Roth W, Porubsky S. Epidemiology of thymomas and thymic carcinomas in the United States and Germany, 1999-2019. Front Oncol. 2024 Jan 9;13:1308989.
2. Vahl JM, Nagel G, Abou Kors T, Brand M, von Witzleben A, Sonntag M, Grages A, Theodoraki MN, Greve J, Denkinger M, Dallmeier D, Idel C, Stilgenbauer S, Hoffmann TK, Laban S. Regional outcome disparities in German head and neck cancer patients: Shorter survival in Eastern Germany. Cancer Med. 2023 Dec;12(23):21426-21435.
3. Vahl JM, Nagel G, Grages A, Brand M, von Witzleben A, Sonntag M, Theodoraki MN, Greve J, Aboukors T, Denkinger M, Dallmeier D, Idel C, Hoffmann TK, Laban S. Demographics and access to head and neck cancer care in rural areas compared to urban areas in Germany. Cancer Med. 2023 Sep;12(18):18826-18836.
4. Neumeyer S, Tanaka LF, Liang LA, Klug SJ. Epidemiology of cervical cancer in elderly women: Analysis of incidence, treatment, and survival using German registry data. Cancer Medicine. 2023 Aug;12(16):17284-95.
5. Kraywinkel K, Flegar L, Huber J, Groeben C. Krebsregister in Deutschland: Was bringt die Zukunft für die Urologie? [Cancer registries in Germany: what does the future hold for urology?] Aktuelle Urol. 2023 Jun;54(3):208-212. German.
6. Tanaka LF, Figueroa SH, Popova V, Klug SJ, Buttmann-Schweiger N. The Rising Incidence of Early-Onset Colorectal Cancer. Dtsch Arztebl Int. 2023 Feb 3;120(Forthcoming):59-64.
7. Köhler F, Reese L, Hendricks A, Kastner C, Müller S, Lock JF, Germer CT, Wiegering A. Low-grade mucinous neoplasms (LAMN) of the appendix in Germany between 2011 and 2018: a nationwide analysis based on data provided by the German Center for Cancer Registry Data (ZfKD) at the Robert Koch Institute (RKI). Langenbecks Arch Surg. 2022 Dec;407(8):3615-3622.
8. Abele M, Voggel S, Bremensdorfer C, Spix C, Erdmann F, Kuhlen M, Redlich A, Ebinger M, Lang P, Schneider DT, Brecht IB. Incidences and characteristics of primary lung malignancies in childhood in Germany: An analysis of population-based data from German cancer registries. Pediatr Blood Cancer. 2022 Sep;69(9):e29744.
9. Jansen L, Moratin J, Waldmann A, Zaoui K, Holleczek B, Nennecke A, Pritzkuleit R, Plinkert PK, Hoffmann J, Arndt V. Mundhöhlen- und Pharynxkarzinome: Inzidenz, Mortalität und Überleben in Deutschland [Oral and pharyngeal cancer: incidence, mortality, and survival in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Aug;64(8):941-950. German.
10. Bedir A, Abera SF, Efremov L, Hassan L, Vordermark D, Medenwald D. Socioeconomic disparities in head and neck cancer survival in Germany: a causal mediation analysis using population-based cancer registry data. Journal of cancer research and clinical oncology. 2021 May;147:1325-34.
Apr 13, 2021: Our first database profile from Egypt
The Egypt National Population-based Cancer Registry (NPCR) was established in 2007 and is the only source for cancer incidence in the whole of Egypt. It routinely collects patient data from peripheral population-based registries in the cancer centers of the 5 governorates. Data include patient demographics, primary tumor site, tumor morphology, stage at diagnosis, and follow-up for vital status from over one million patients.
Egypt National Population-based Cancer Registry (NPCR) (Egypt)
Database Contact Data
Amal Ibrahim, MD, DrPH
Emeritus Professor of Epidemiology
National Cancer Institute, Cairo University
Director National Cancer Registry Program
13, Street 207 Maadi,
Cairo 11728
EGYPT
Phone: +2 01006030480
Email: ibrahimamalsamy@gmail.com
Alternate Contact
N/A
References of Studies Using/Describing Database
1. Ibrahim AS, Mikhail NN, Khaled H. Current and future incidence of childhood cancer in Egypt: results of the national population-based cancer registry. J Cancer PrevCurr Res. 2018;9(6):316-21.
2. Ibrahim AS, Nazmi N. Cancer: the growing monster in Egypt. J Cancer Prev Curr Res. 2016;6(4):217.
3. Ibrahim AS, Mikhail NN. The evolution of cancer registration in Egypt: From proportions to population-based incidence rates. SECI Oncology. 2015; 3(1):23-43.
4. Azim HA, Ibrahim AS. Breast cancer in Egypt, China and Chinese: statistics and beyond. J Thorac Dis. 2014 Jul;6(7):864-6.
5. Ibrahim AS, Khaled HM, Mikhail NN, Baraka H, Kamel H. Cancer incidence in egypt: results of the national population-based cancer registry program. J Cancer Epidemiol. 2014;2014:437971.
6. Alieldin NH, Abo-Elazm OM, Bilal D, Salem SE, Gouda E, Elmongy M, Ibrahim AS. Age at diagnosis in women with non-metastatic breast cancer: Is it related to prognosis?. Journal of the Egyptian National Cancer Institute. 2014 Mar 1;26(1):23-30.
7. Soliman AS, Banerjee M, Lo AC, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Omar HG, Fokuda A, Harford JB, Merajver SD. High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt. Breast J. 2009 Jul-Aug;15(4):432-4.
8. Barchana M, Ibrahim AS, Mikhail N. MOS Epidemiology Group Special report: cancer incidence in Mediterranean populations. Mediterranean Oncology Society Web site. 2009.
9. Ibrahim AS, Ismail K, Hablas A, Hussein H, Elhamzawy H, Ramadan M. Cancer in Egypt, Gharbiah. Triennial Report of 2000–2002. Gharbiah Population-Based Cancer Registry. 2007.
10. Ibrahim AS. Descriptive statistics of urogenital cancer in Egypt and Asian area. Tunis Med. 2005 Dec;83 Suppl 12:15-7.
Apr 5, 2020: Two new National Health and Wellness Survey (NHWS) offerings from Kantar
Kantar's latest NHWS, from South Korea and Taiwan, are the latest to be profiled in B.R.I.D.G.E. TO DATA. These databases provide demographic data, disease-specific measures on >165 conditions (including symptoms & comorbidities), patient-reported outcomes (including quality of life), patient attitudes, medication and healthcare resource utilization. The survey aims to collect data to show how patients view their health, their attitudes and behaviors, outcomes and their unmet needs.